{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:43:15Z","timestamp":1780533795669,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.clineuro.2010.04.010","type":"journal-article","created":{"date-parts":[[2010,7,9]],"date-time":"2010-07-09T08:18:55Z","timestamp":1278663535000},"page":"592-596","source":"Crossref","is-referenced-by-count":25,"title":["The place of the botulinum toxin in the management of multiple sclerosis"],"prefix":"10.1016","volume":"112","author":[{"given":"Mario","family":"Habek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Karni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakov","family":"Balash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2010.04.010_bib1","first-page":"60","article-title":"Managing specific symptoms in people with multiple sclerosis","volume":"12","author":"Henze","year":"2005","journal-title":"Int MS J"},{"key":"10.1016\/j.clineuro.2010.04.010_bib2","series-title":"Spasticity: disordered motor control Chicago","article-title":"Symposium synopsis","author":"Lance","year":"1980"},{"key":"10.1016\/j.clineuro.2010.04.010_bib3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/(SICI)1097-4598(1997)6+<14::AID-MUS3>3.0.CO;2-M","article-title":"A clinical overview of treatment decisions in the management of spasticity","volume":"6","author":"Gormley","year":"1997","journal-title":"Muscle Nerve Suppl"},{"key":"10.1016\/j.clineuro.2010.04.010_bib4","first-page":"1041","article-title":"Spasticity and multiple sclerosis","volume":"157","author":"Bussel","year":"2001","journal-title":"Rev Neurol (Paris)"},{"issue":"4","key":"10.1016\/j.clineuro.2010.04.010_bib5","first-page":"CD001332","article-title":"Anti-spasticity agents for multiple sclerosis","author":"Shakespeare","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.clineuro.2010.04.010_bib6","doi-asserted-by":"crossref","first-page":"I26","DOI":"10.1007\/s00415-006-1106-y","article-title":"Botulinum toxin in patients with multiple sclerosis","volume":"253","author":"Kabus","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.clineuro.2010.04.010_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.410280407","article-title":"Treatment of spasticity with botulinum toxin: a double-blind study","volume":"28","author":"Snow","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2010.04.010_bib8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00002060-199312000-00005","article-title":"Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations","volume":"72","author":"Borg-Stein","year":"1993","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.clineuro.2010.04.010_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00002826-199706000-00002","article-title":"Automatic EMG-guided botulinum toxin treatment of spasticity","volume":"20","author":"Finsterer","year":"1997","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.clineuro.2010.04.010_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jnnp.68.6.707","article-title":"Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study","volume":"68","author":"Hyman","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.clineuro.2010.04.010_bib11","first-page":"3","article-title":"The application of botulinum toxin type A in the treatment of spastic paraparesis","volume":"64","author":"Sobolewski","year":"2007","journal-title":"Przegl Lek"},{"key":"10.1016\/j.clineuro.2010.04.010_bib12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/01.WNL.0000080081.74117.E4","article-title":"Botulinum toxin treatment of painful tonic spasms in multiple sclerosis","volume":"61","author":"Restivo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.04.010_bib13","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1016\/j.apmr.2007.06.668","article-title":"Botulinum toxin type B treatment in multiple sclerosis patients with lower-extremity adductor spasticity: results of a double-blind, placebo-controlled, safety study","volume":"88","author":"Pappert","year":"2007","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clineuro.2010.04.010_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/0269215507072772","article-title":"Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis","volume":"21","author":"Giovannelli","year":"2007","journal-title":"Clin Rehabil"},{"issue":"Suppl. 1","key":"10.1016\/j.clineuro.2010.04.010_bib15","doi-asserted-by":"crossref","first-page":"I16","DOI":"10.1007\/s00415-006-1104-0","article-title":"Botulinum toxin in multiple sclerosis","volume":"253","author":"Jost","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.clineuro.2010.04.010_bib16","series-title":"British Society of Rehabilitation Medicine, Chartered Society of Physiotherapy, Association of Chartered Physiotherapists Interested in Neurology\/Spasticity in adults: management using botulinum toxin. National guidelines","author":"Royal College of Physicians","year":"2009"},{"issue":"Suppl. 4","key":"10.1016\/j.clineuro.2010.04.010_bib17","first-page":"20","article-title":"Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis","volume":"113","author":"Wissel","year":"2001","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.clineuro.2010.04.010_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0168-6054(03)00106-5","article-title":"Multiple sclerosis and botulinum toxin","volume":"46","author":"Lamotte","year":"2003","journal-title":"Ann Readapt Med Phys"},{"key":"10.1016\/j.clineuro.2010.04.010_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.urology.2005.04.061","article-title":"Understanding detrusor sphincter dyssynergia \u2013 significance of chronology","volume":"66","author":"Karsenty","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.clineuro.2010.04.010_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.clineuro.2010.04.010_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0090-4295(00)00761-5","article-title":"Clinical significance of detrusor sphincter dyssynergia type in patients with post-traumatic spinal cord injury","volume":"56","author":"Weld","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.clineuro.2010.04.010_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0022-5347(01)63048-9","article-title":"Vesicourethral dysfunction associated with multiple sclerosis: clinical and urodynamic perspectives","volume":"160","author":"Barbalias","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.clineuro.2010.04.010_bib23","first-page":"24","article-title":"Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study","volume":"71","author":"Dykstra","year":"1990","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clineuro.2010.04.010_bib24","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/jnnp.2004.045765","article-title":"Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients","volume":"76","author":"Gallien","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2010.04.010_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/nau.20153","article-title":"Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis","volume":"25","author":"Schulte-Baukloh","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.clineuro.2010.04.010_bib26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21209","article-title":"Botulinum injections for the treatment of bladder symptoms of multiple sclerosis","volume":"62","author":"Kalsi","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clineuro.2010.04.010_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/00365590601068835","article-title":"Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo controlled, double-blind study","volume":"41","author":"Ehren","year":"2007","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.clineuro.2010.04.010_bib28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.eururo.2005.12.015","article-title":"Successful treatment with intradetrusor Botulinum-A toxin for urethral urinary leakage (catheter bypassing) in patients with end-staged multiple sclerosis and indwelling suprapubic catheters","volume":"50","author":"Lekka","year":"2006","journal-title":"Eur Urol"},{"issue":"40","key":"10.1016\/j.clineuro.2010.04.010_bib29","doi-asserted-by":"crossref","DOI":"10.3310\/hta7400","article-title":"Treatments for spasticity and pain in multiple sclerosis: a systematic review","volume":"7","author":"Beard","year":"2003","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.clineuro.2010.04.010_bib30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ncpneuro0948","article-title":"Botulinum neurotoxins in the treatment of refractory pain","volume":"4","author":"Jabbari","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.clineuro.2010.04.010_bib31","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.clineuro.2008.02.009","article-title":"Isolated cranial nerve palsies in multiple sclerosis","volume":"110","author":"Zadro","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.clineuro.2010.04.010_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.clineuro.2010.04.010_bib33","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","author":"Brin","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.04.010_bib34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/WNL.45.4.822","article-title":"Botulinum toxin treatment of essential head tremor","volume":"45","author":"Pahwa","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.04.010_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000008152","article-title":"Continuous facial myokymia in multiple sclerosis: treatment with botulinum toxin","volume":"43","author":"Sedano","year":"2000","journal-title":"Eur Neurol"},{"key":"10.1016\/j.clineuro.2010.04.010_bib36","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaapos.2007.03.005","article-title":"Botulinum toxin in the management of internuclear ophthalmoplegia","volume":"11","author":"Murthy","year":"2007","journal-title":"J AAPOS"},{"key":"10.1016\/j.clineuro.2010.04.010_bib37","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/archopht.1994.01090220070025","article-title":"Treatment of acquired nystagmus with botulinum neurotoxin A","volume":"112","author":"Repka","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clineuro.2010.04.010_bib38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0161-6420(94)31265-6","article-title":"The use of botulinum toxin for treatment of acquired nystagmus and oscillopsia","volume":"101","author":"Ruben","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clineuro.2010.04.010_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1034\/j.1600-0420.1998.760106.x","article-title":"Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications","volume":"76","author":"Lennerstrand","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.clineuro.2010.04.010_bib40","first-page":"817","article-title":"Auditory dysfunction caused by multiple sclerosis: detection with MR imaging","volume":"11","author":"Cur\u00e9","year":"1990","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.clineuro.2010.04.010_bib41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.otohns.2005.02.015","article-title":"Evaluation of botulinum toxin A in treatment of tinnitus","volume":"132","author":"Stidham","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clineuro.2010.04.010_bib42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pain.2008.12.026","article-title":"Trigeminal neuralgia and pain related to multiple sclerosis","volume":"43","author":"Cruccu","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.clineuro.2010.04.010_bib43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1212\/01.wnl.0000180940.98815.74","article-title":"An open study of botulinum-A toxin treatment of trigeminal neuralgia","volume":"65","author":"Piovesan","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2010.04.010_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1191\/1352458506ms1294cr","article-title":"Gastroparesis with multiple sclerosis","volume":"12","author":"Raghav","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.clineuro.2010.04.010_bib45","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1365-2036.2007.03467.x","article-title":"Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis","volume":"26","author":"Arts","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clineuro.2010.04.010_bib46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1572-0241.2007.01676.x","article-title":"Botulinum toxin A for the treatment of delayed gastric emptying","volume":"103","author":"Friedenberg","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clineuro.2010.04.010_bib47","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00383-008-2171-3","article-title":"Botulinum toxin for the treatment of chronic constipation in children with internal anal sphincter dysfunction","volume":"24","author":"Irani","year":"2008","journal-title":"Pediatr Surg Int"},{"issue":"June (6)","key":"10.1016\/j.clineuro.2010.04.010_bib48","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/PHM.0b013e3181a5b056","article-title":"Contralateral weakness and fatigue after high-dose botulinum toxin injection for management of poststroke spasticity","volume":"88","author":"Varghese-Kroll","year":"2009","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.clineuro.2010.04.010_bib49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/jnnp.67.1.90","article-title":"Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases","volume":"67","author":"Bhatia","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clineuro.2010.04.010_bib50","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/jnnp.2006.090365","article-title":"Costs and quality of life of patients with multiple sclerosis in Europe","volume":"77","author":"Kobelt","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"December (Suppl. 4)","key":"10.1016\/j.clineuro.2010.04.010_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1468-1331.2006.01651.x","article-title":"Improvements in healthcare and cost benefits associated with botulinum toxin treatment of spasticity and muscle overactivity","volume":"13","author":"Esquenazi","year":"2006","journal-title":"Eur J Neurol"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846710001125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846710001125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T18:24:10Z","timestamp":1544379850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846710001125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0303846710001125"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2010.04.010","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}